What is the appropriate nebulized levosalbutamol dose for this child?

Nebulized Levosalbutamol Dosing for Children

For children aged 4-11 years with asthma, start with nebulized levosalbutamol 0.31 mg three times daily, which provides equivalent efficacy to racemic salbutamol 1.25-2.5 mg with superior safety. 1, 2

Dosing by Age and Severity

Children 4-11 Years Old

• Starting dose: 0.31 mg nebulized three times daily 2
• This dose is clinically comparable to 4-8 fold higher doses of racemic albuterol 2
• For severe asthma exacerbations: 0.63 mg may be used, as a dose-response relationship exists in severe disease 2
• Maximum studied dose: 1.25 mg, which showed greatest FEV₁ improvement over 8 hours 3

Children 2-5 Years Old

• 0.31 mg or 0.63 mg nebulized three times daily (dosing without regard to weight) 4
• Both doses were well-tolerated and led to significant bronchodilation compared to placebo 4
• The 0.63 mg dose caused significant increases in heart rate, while 0.31 mg did not differ from placebo for cardiac effects 4

Acute Severe Asthma

• Initial dose: 0.63 mg, repeated as needed 5
• Treatment may be repeated within minutes if suboptimal response, or continuous nebulization until stable 6
• Change to hand-held inhalers once condition stabilizes 6

Key Safety Advantages Over Racemic Albuterol

Levosalbutamol 0.31 mg is the only bronchodilator dose that does not differ from placebo for:

• Ventricular heart rate changes 2
• QTc interval prolongation 2
• Glucose elevation 2

All active treatments decrease serum potassium, but racemic albuterol 2.5 mg causes the greatest reduction 2

Clinical Efficacy Evidence

The superiority of levosalbutamol over racemic formulations is demonstrated by:

• Faster wheezing remission: 2.7 vs 3.8 days 5
• Better respiratory parameters: Lower respiratory rate (24.4 vs 27.6/min), higher SpO₂ (97.2% vs 95.0%), higher PEFR (159.6 vs 143.8 L/min) 5
• Less tachycardia: Heart rate 115.5 vs 124.5/min 5

Important Caveats

• One systematic review found no significant difference between levalbuterol and albuterol for acute asthma 7, though this meta-analysis included heterogeneous populations and dosing regimens
• The therapeutic advantage comes from avoiding the (S)-enantiomer, which may increase airway hyperreactivity 8
• For inhaler formulation (ages ≥4 years): 2 inhalations (90 mcg total) every 4-6 hours; some patients may need only 1 inhalation every 4 hours 1